Gene · 9582
Papers1,875
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,875
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Construction of a novel radioresistance-related signature for prediction of prognosis, immune microenvironment and anti-tumour drug sensitivity in non-small cell lung cancer. | Ann Med | 2025 | 39797413 | PubTator, text mining | PubMed |
| Complex rearrangements fuel ER+ and HER2+ breast tumours. | Nature | 2025 | 39779850 | PubTator, text mining | PubMed |
| APOBEC3A deaminates CTG hairpin loops to promote fragility and instability of expanded CAG/CTG repeats. | Proc Natl Acad Sci U S A | 2025 | 39772743 | PubTator, text mining | PubMed |
| The Impact of Sugar Conformation on the Single-Stranded DNA Selectivity of APOBEC3A and APOBEC3B Enzymes. | ACS Chem Biol | 2025 | 39680033 | PubTator, text mining | PubMed |
| Analysis of the progression of cervical cancer in a low-and-middle-income country: From pre-malignancy to invasive disease. | Tumour Virus Res | 2025 | 39672307 | PubTator, text mining | PubMed |
| Differentiation signals induce APOBEC3A expression via GRHL3 in squamous epithelia and squamous cell carcinoma. | EMBO J | 2025 | 39548236 | PubTator, text mining | PubMed |
| Computational drug discovery of an inhibitor of APOBEC3B as a treatment for epithelial cancers. | J Biomol Struct Dyn | 2025 | 38109103 | PubTator, text mining | PubMed |
| DEPDC1B, CDCA2, APOBEC3B, and TYMS are potential hub genes and therapeutic targets for diagnosing dialysis patients with heart failure. | Front Cardiovasc Med | 2024 | 39844908 | PubTator, text mining | PubMed |
| Untargeted Mutation Triggered by Ribonucleoside Embedded in DNA. | Int J Mol Sci | 2024 | 39769470 | PubTator, text mining | PubMed |
| Trimesic Acid as a Building Block for Ternary and Quaternary Salts and Salt Cocrystals. | Cryst Growth Des | 2024 | 39583627 | PubTator, text mining | PubMed |
| Validation of the APOBEC3A-Mediated RNA Single Base Substitution Signature and Proposal of Novel APOBEC1, APOBEC3B, and APOBEC3G RNA Signatures. | J Mol Biol | 2024 | 39510348 | PubTator, text mining | PubMed |
| Apolipoprotein-B mRNA-editing complex 3B could be a new potential therapeutic target in endometriosis. | Sci Rep | 2024 | 39443671 | PubTator, text mining | PubMed |
| The Mechanism of APOBEC3B in Hepatitis B Virus Infection and HBV Related Hepatocellular Carcinoma Progression, Therapeutic and Prognostic Potential. | Infect Drug Resist | 2024 | 39435460 | PubTator, text mining | PubMed |
| APOBEC3B expression in 293T viral producer cells drives mutations in chimeric antigen receptors and reduces CAR T cell efficacy. | Mol Ther Oncol | 2024 | 39403625 | PubTator, text mining | PubMed |
| p-STAT3-elevated E3 ubiquitin ligase DTX4 confers the stability of HBV cccDNA by ubiquitinating APOBEC3B in liver. | Theranostics | 2024 | 39346550 | PubTator, text mining | PubMed |
| Characterisation of APOBEC3B-Mediated RNA editing in breast cancer cells reveals regulatory roles of NEAT1 and MALAT1 lncRNAs. | Oncogene | 2024 | 39322638 | PubTator, text mining | PubMed |
| APOBEC family reshapes the immune microenvironment and therapy sensitivity in clear cell renal cell carcinoma. | Clin Exp Med | 2024 | 39249558 | PubTator, text mining | PubMed |
| Genetic alteration of mRNA editing enzyme APOBEC3B in the pathogenesis of ovarian endometriosis. | Reprod Biomed Online | 2024 | 39197402 | PubTator, text mining | PubMed |
| Regulation, functional impact, and therapeutic targeting of APOBEC3A in cancer. | DNA Repair (Amst) | 2024 | 39047499 | PubTator, text mining | PubMed |
| The role of distinct APOBEC/ADAR mRNA levels in mutational signatures linked to aging and ultraviolet radiation. | Sci Rep | 2024 | 38965255 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9582/papers?page=5